Effect of hypothalamic administration of growth hormone-releasing factor (GRF) on feeding behavior in rats.
To examine the role and working site of growth hormone-releasing factor (GRF) in feeding behavior, we first tested the effect of the intracerebroventricular (i.c.v.) injection of GRF on food intake after 24 h of food deprivation. Cumulative food intake was measured 1, 3 and 6 h after injection. A lower dose of GRF stimulated food intake in a dose dependent manner (3 h; GRF 100 pmol 8.64 +/- 1.06 g vs saline 5.50 +/- 0.60 g, P less than 0.05), while a higher dose (1 nmol, 500 pmol) suppressed food intake (3 h; GRF 1 nmol 2.65 +/- 0.70 g vs saline 5.50 +/- 0.60 g, P less than 0.01). Second, the effect of i.c.v. injection of 100 pmol of GRF on peripheral metabolites was examined. The subsequent levels of plasma insulin, glucagon, glucose and non-esterified fatty acid showed no significant difference from those of saline administration. Third, the effect of microinjection of GRF (5 pmol) into several hypothalamic areas on food intake was examined. Injection into the ventromedial hypothalamic nucleus (VMN) stimulated food intake (3 h; GRF 5 pmol 10.32 +/- 1.04 g vs saline 6.92 +/- 0.32 g, P less than 0.05), but no significant effect was observed following injection either into the lateral hypothalamic area (LHA), paraventricular nucleus (PVN) or medial preoptic area (MPOA). Finally, we tested the stimulatory effect of GRF on food intake in bilateral VMN lesioned rats. I.c.v. injection in these animals had no more significant effect on food intake than did saline injection in VMN lesioned rats (3 h; GRF 100 pmol 6.27 +/- 0.87 g vs saline 5.34 +/- 0.44 g).(ABSTRACT TRUNCATED AT 250 WORDS)
Tanaka
Y
Y
Third Department of Internal Medicine, Yokohama City University, Japan.
Egawa
M
M
Inoue
S
S
Takamura
Y
Y
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005227:Fatty Acids / Q000097:blood; D005247:Feeding Behavior / Q000187:drug effects*; D005260:Female; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D007026:Hypothalamic Area, Lateral; D007031:Hypothalamus / Q000033:anatomy & histology; D007276:Injections, Intraventricular; D007328:Insulin / Q000494:pharmacology; D008845:Microinjections; D011301:Preoptic Area; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014697:Ventromedial Hypothalamic Nucleus
D005227:Fatty Acids; D007328:Insulin; D013007:Growth Hormone-Releasing Hormone